Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma ; volume:11 ; number:1 ; day:27 ; month:11 ; year:2023 ; pages:1-13 ; date:12.2023
Acta Neuropathologica Communications ; 11, Heft 1 (27.11.2023), 1-13, 12.2023
- Creator
-
Tateishi, Kensuke
Miyake, Yohei
Nakamura, Taishi
Iwashita, Hiromichi
Hayashi, Takahiro
Oshima, Akito
Honma, Hirokuni
Hayashi, Hiroaki
Sugino, Kyoka
Kato, Miyui
Satomi, Kaishi
Fujii, Satoshi
Komori, Takashi
Yamamoto, Tetsuya
Cahill, Daniel P.
Wakimoto, Hiroaki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-023-01683-x
- URN
-
urn:nbn:de:101:1-2024021413132999452379
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tateishi, Kensuke
- Miyake, Yohei
- Nakamura, Taishi
- Iwashita, Hiromichi
- Hayashi, Takahiro
- Oshima, Akito
- Honma, Hirokuni
- Hayashi, Hiroaki
- Sugino, Kyoka
- Kato, Miyui
- Satomi, Kaishi
- Fujii, Satoshi
- Komori, Takashi
- Yamamoto, Tetsuya
- Cahill, Daniel P.
- Wakimoto, Hiroaki
- SpringerLink (Online service)
Other Objects (12)
Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Renal alterations in Pou3f3L423P mutant mice
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Pilomyxoid Astrocytoma: Case Report
T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Renal alterations in Pou3f3L423P mutant mice
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Pilomyxoid Astrocytoma: Case Report
T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Renal alterations in Pou3f3L423P mutant mice
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Pilomyxoid Astrocytoma: Case Report